$3 million GSK verdict thrown out of court
August 23, 2018Sales and Marketing GSK, Litigation, antidepressants, suicide, verdict
A $3 million verdict against British multinational GlaxoSmithKline has been thrown out after a US appeals court said that GSK …
Novartis’ investigational combo impresses in breast cancer sub-group
August 23, 2018Research and Development Cancer, Novartis, breast cancer, fulvestrant, pharma
Novartis has revealed positive new data for its investigational alpha-specific PI3K inhibitor BYL719 (alpelisib) combined with fulvestrant in the treatment …
Nerve stimulation treatments improve quality of life in depressed people, study shows
August 23, 2018Research and Development VNS, depression, neuroscience, psychiatry, quality of life, vagus nerve stimulators
Nerve stimulation treatments can significantly improve depressed people’s quality of life, even in cases in which an individual continues to …
FDA refuses Allergan’s uterine bleeding therapy with a request for more data
August 22, 2018Research and Development, Sales and Marketing Allergan, Esmya, FDA, pharma
Allergan has shared the news that the FDA has refused to award marketing authorisation to its ulipristal acetate product Esmya …
Brexit Health Alliance calls for effective planning for no-deal Brexit
August 22, 2018Research and Development Brexit Health Alliance, Labour, NHS, brexit, no-deal
Niall Dickson, co-chair of the Brexit Health Alliance has called for immediate comprehensive and effective plans for a no deal …
Novo Nordisk buys Bristol University biotech in £620m deal
August 22, 2018Research and Development Bristol, Novo Nordisk, Ziylo, diabetes
Novo Nordisk has bought a tiny biotech company spun out of Bristol University in a deal that could be worth …
Blockchain deployed in fight against fake pharmaceuticals in India
August 22, 2018Research and Development India, NITI, blockchain, pharma, technology
Indian policymakers in collaboration with an Indian hospital chain and an American multinational, have initiated plans to deploy blockchain technology …
Alex Azar says his agency has the power to eliminate pharmaceutical rebates
August 21, 2018Research and Development Alex Azar, Rebates, Trump, US government, pbm
US Health and Human Services Secretary Alex Azar has said in an interview with Reuters, that it is within the …
Novo’s semaglutide hits the mark in Phase 3 type 2 diabetes study
August 21, 2018Manufacturing and Production, Research and Development Novo Nordisk, diabetes, pharma, semaglutide, type 2 diabetes
Novo Nordisk has revealed new Phase 3a data on its glucagon-like peptide-1 (GLP-1) analogue oral semaglutide in the treatment of …
Leaked letter warns of NHS disruption after Brexit
August 21, 2018Manufacturing and Production NHS, The Times, brexit, hard Brexit
NHS Providers, the membership organisation and trade association for professionals working in the NHS, has warned that the NHS is …
Japan approves AstraZeneca’s Tagrisso in EGFRm non-small cell lung cancer
August 21, 2018Manufacturing and Production, Sales and Marketing AstraZeneca, Cancer, Japan, Tagrisso, lung cancer, pharma
AstraZeneca has revealed that its EGFR tyrosine kinase inhibitor Tagrisso (osimertinib) has been approved in Japan by the nation’s Ministry …
Further six officials fired from China FDA
August 21, 2018Manufacturing and Production CFDA, Changsheng biotechnology, China, Vaccine, scandal
A further six senior officials from the China Food and Drug Administration (CFDA) have been fired in relation to the …
Prozac prevents cognitive decline during normal aging process, study shows
August 21, 2018Manufacturing and Production MIT, Picower Institute, Prozac, antidepressants, mice, neuroscience
A study conducted by MIT’s Picower Institute for Learning and Memory has reinforced the notion that loss in the capacity …
FDA approves Bristol Myers Squibb’s Opdivo in small-cell lung cancer
August 20, 2018Sales and Marketing Bristol-Myers Squibb, FDA, approval, bristol myers squibb, lung cancer, opdivo
The FDA has approved Bristol Myers Squibb’s Opdivo (nivolumab) for patients with metastatic small-cell lung cancer (SCLC), as the first …
Regeneron’s Eylea wins FDA approval for wet age-related macular degeneration
August 20, 2018Sales and Marketing Bayer, Eylea, FDA, Regeneron, US, pharma
Regeneron is celebrating the approval in the US of its vascular endothelial growth factor (VEGF) inhibitor Eylea (aflibercept) for the …
Thyroid medication recalled after Chinese supplier fails inspection
August 20, 2018Sales and Marketing China, FDA, recall, thyroid, westminster
The Mississippi based manufacturer Westminster Pharmaceuticals is voluntarily recalling thyroid medications Levothyroxine and Liothyronine after the Chinese company Sichuan Friendly …
More children suffering from type 2 diabetes in England and Wales
August 20, 2018Sales and Marketing England, NHS, Wales, children, diabetes, obesity, young people
The number of children and young people suffering from type-2 diabetes has increased in England in Wales over the past …
Chinese regulators approve Roche’s Alecensa in regulatory shift
August 20, 2018Sales and Marketing Cancer, China, Roche, approval, lung cancer
China’s National Drug Administration has granted rapid approval for Roche’s lung cancer treatment Alecensa (alectinib). Chinese regulators have in the …
Gilead CMO announces departure alongside two new exec appointments
August 17, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, pharma
Gilead has announced that its Chief Medical Officer is to vacate the role after just five months and leave the …
FDA approves first-ever generic EpiPen versions, courtesy of Teva
August 17, 2018Medical Communications, Sales and Marketing FDA, Mylan, Teva, US, epipen, pharma
The FDA has announced the approval of the first generic versions of Mylan’s EpiPen and EpiPen Jr epinephrine auto-injectors as …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
